Correlation Between National CineMedia and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both National CineMedia and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National CineMedia and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National CineMedia and Abcellera Biologics, you can compare the effects of market volatilities on National CineMedia and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National CineMedia with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of National CineMedia and Abcellera Biologics.
Diversification Opportunities for National CineMedia and Abcellera Biologics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between National and Abcellera is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding National CineMedia and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and National CineMedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National CineMedia are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of National CineMedia i.e., National CineMedia and Abcellera Biologics go up and down completely randomly.
Pair Corralation between National CineMedia and Abcellera Biologics
Given the investment horizon of 90 days National CineMedia is expected to generate 4.97 times less return on investment than Abcellera Biologics. But when comparing it to its historical volatility, National CineMedia is 1.75 times less risky than Abcellera Biologics. It trades about 0.03 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 250.00 in Abcellera Biologics on September 2, 2024 and sell it today you would earn a total of 51.00 from holding Abcellera Biologics or generate 20.4% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
National CineMedia vs. Abcellera Biologics
Performance |
Timeline |
National CineMedia |
Abcellera Biologics |
National CineMedia and Abcellera Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with National CineMedia and Abcellera Biologics
The main advantage of trading using opposite National CineMedia and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National CineMedia position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.National CineMedia vs. MGO Global Common | National CineMedia vs. Baosheng Media Group | National CineMedia vs. Glory Star New | National CineMedia vs. Impact Fusion International |
Abcellera Biologics vs. Tff Pharmaceuticals | Abcellera Biologics vs. Eliem Therapeutics | Abcellera Biologics vs. Inhibrx | Abcellera Biologics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |